Phenotypic characterization of B cells and serum cytokine responses during Tuberculosis and Type 2 Diabetes

Simple item page
dc.contributor.advisorKleynhans, Leanieen_ZA
dc.contributor.advisorLoxton, Andre G.en_ZA
dc.contributor.authorShabangu, Ayanda Noncedoen_ZA
dc.contributor.otherStellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Biomedical Sciences: Molecular Biology and Human Geneticsen_ZA
dc.date.accessioned2019-11-26T13:33:27Z
dc.date.accessioned2019-12-11T06:39:42Z
dc.date.available2019-11-26T13:33:27Z
dc.date.issued2019-12
dc.descriptionThesis (MSc)--Stellenbosch University, 2019.en_ZA
dc.description.abstractENGLISH ABSTRACT: Tuberculosis (TB) remains a world pandemic, claiming the lives of 1.7 million people in 2017. Several risk factors have been identified as key attributes to the development of TB, such as type 2 diabetes (T2D). Cellular function of immune cell types are altered in TB-T2D patients compared to TB patients, leaving the host vulnerable to increased Mycobacterium tuberculosis (Mtb) replication and enhanced disease severity. Emphasis has been placed on the role of T-cells and macrophages in TB-T2D comorbidity, however, B-cells also play a fundamental role in the adaptive immune response to TB. Since limited information is available on the frequency of B cells in TB in the context of T2D, we aimed to determine the frequencies of regulatory and killer B-cell, through the expression of the cell surface markers, FasL (CD178+) and IL-5Rα (CD125+). In addition, we investigate imbalances in host immune markers in healthy controls, T2D patients and TB patients with and without T2D. The immunological responses, including regulatory, memory and apoptotic B-cell function, are impaired in T2D, TB and TB-T2D patients at the initiation of TB treatment, and improve in TB and TB-T2D patients following two months into anti-TB treatment. In addition, markers associated with cell proliferation, cell development, chemotactic function, granuloma formation and monocyte recruitment are impaired, highlighting the need for effective T2D management in combating TB.en_ZA
dc.description.abstractAFRIKAANSE OPSOMMING: Tuberkulose (TB) bly 'n wêreldpandemie wat die lewens van 1,7 miljoen mense in 2017 geëis het. Verskeie risikofaktore is geïdentifiseer as sleutelkenmerke vir die ontwikkeling van TB, soos tipe 2-diabetes (T2D). Die sellulêre funksie van immuunselle in TB-T2D-pasiënte is anders in vergelyking met TB-pasiënte, wat die gasheer kwesbaar maak vir verhoogde Mycobacterium tuberculosis (Mtb) replikasie en die erns van die siekte verhoog. Klem is gelê op die rol van T-selle en makrofage in die TB-T2D mede-morbiditeit. B-selle speel egter ook 'n fundamentele rol in die aanpasbare immuunrespons op TB. Aangesien beperkte inligting beskikbaar is oor die frekwensie van B-selle in TB in die konteks van T2D, het ons ten doel gehad om die frekwensies van regulatoriese en moordenaar B-selle te bepaal, deur die uitdrukking van die seloppervlakte-merkers, FasL (CD178+) en IL-5Rα (CD125+) te meet. Daarbenewens ondersoek ons wanbalanse in die gasheer immuunmerkers in gesonde kontroles, T2D-pasiënte en TB-pasiënte met en sonder T2D. Die immunologiese reaksies, insluitend regulatoriese, geheue en apoptotiese Bselfunksie, word aangetas in T2D-, TB- en TB-T2D-pasiënte voor die aanvang van TB behandeling, en verbeter in die TB- en TB-T2D-pasiënte na twee maande van TB behandeling. Verder word merkers wat verband hou met selproliferasie, selontwikkeling, chemotaktiese funksie, granuloomvorming en monosiet-werwing benadeel, wat die behoefte aan effektiewe T2D-bestuur in die bestryding van TB benadruk.af_ZA
dc.description.versionMasters
dc.embargo.terms2020-12-11
dc.format.extent100 pagesen_ZA
dc.identifier.urihttp://hdl.handle.net/10019.1/106939
dc.language.isoen_ZAen_ZA
dc.publisherStellenbosch : Stellenbosch Universityen_ZA
dc.rights.holderStellenbosch Universityen_ZA
dc.subjectPhenotypic characterizationen_ZA
dc.subjectType 2 Diabetesen_ZA
dc.subjectTuberculosisen_ZA
dc.subjectCytokinesen_ZA
dc.subjectSerumen_ZA
dc.subjectTuberculosis (TB)en_ZA
dc.subjectDrugs, Antitubercularen_ZA
dc.subjectType 2 Diabetesen_ZA
dc.titlePhenotypic characterization of B cells and serum cytokine responses during Tuberculosis and Type 2 Diabetesen_ZA
dc.typeThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
shabangu_phenotypic_2019.pdf
Size:
3.83 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Masters Degrees (Molecular Biology and Human Genetics)